Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.5.1.3 extracted from

  • Bennett, B.C.; Wan, Q.; Ahmad, M.F.; Langan, P.; Dealwis, C.G.
    X-ray structure of the ternary MTX-NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design (2009), J. Struct. Biol., 166, 162-171.
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
drug development DHFR is a valid drug target Bacillus anthracis

Crystallization (Commentary)

Crystallization (Comment) Organism
enzyme in ternary complex with NADPH and inhibitor methotrexate, soaking of crystals in 0.1 M Bis-Tris, pH 5.5, 0.2 M CaCl2 and 22.5% w/v PEG 3350 supplemented with 5 mM beta-NADPH at 4°C for 8 h, cryoprotection with 20% v/v glycerol and 5 mM beta-NADPH, X-ray diffraction structure determination and analysis at 2.3 A resolution Bacillus anthracis

Inhibitors

Inhibitors Comment Organism Structure
2-(3-(2-(hydroxyimino)-2-(pyridine-4-yl)-6,7-dimethylquinoxalin-2-yl)-1-(pyridine-4-yl)ethanone) oxime i.e. 373265, a dual-site inhibitor, that targets both the substrate and cofactor binding site, docking modelling, overview Bacillus anthracis
6-amino-3-pentadecylphenyl beta-D-glucoside i.e. 1357, a dual-site inhibitor, that targets both the substrate and cofactor binding site Bacillus anthracis
methotrexate
-
Bacillus anthracis
additional information the enzyme from Bacillus anthracis is naturally resistant to trimethoprim, at least in part due to the presence of a Phe96 substitution in the putative trimethoprim binding site of the enzyme. Inhibitor development by virtual screening for dual-site inhibitors, overview Bacillus anthracis

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
7,8-dihydrofolate + NADPH + H+ Bacillus anthracis
-
5,6,7,8-tetrahydrofolate + NADP+
-
?

Organism

Organism UniProt Comment Textmining
Bacillus anthracis Q81R22
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
7,8-dihydrofolate + NADPH + H+
-
Bacillus anthracis 5,6,7,8-tetrahydrofolate + NADP+
-
?

Synonyms

Synonyms Comment Organism
DHFR
-
Bacillus anthracis

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
25
-
assay at Bacillus anthracis

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
7.1
-
assay at Bacillus anthracis

Cofactor

Cofactor Comment Organism Structure
NADPH binding strutcure and conformation, the adenine moiety adopts an off-plane tilt of nearly 90° and this orientation is stabilized by hydrogen bonds to functionally conserved Arg residues, hydrid transfer and structural role in catalytic mechanism, overview Bacillus anthracis

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0165
-
pH 7.1, 25°C Bacillus anthracis 6-amino-3-pentadecylphenyl beta-D-glucoside
0.074
-
pH 7.1, 25°C Bacillus anthracis 2-(3-(2-(hydroxyimino)-2-(pyridine-4-yl)-6,7-dimethylquinoxalin-2-yl)-1-(pyridine-4-yl)ethanone) oxime

General Information

General Information Comment Organism
physiological function DHFR is essential for the survival and pathogenesis of anthrax. DHFR is required for de novo DNA synthesis and amino acid synthesis Bacillus anthracis